In this context, MCT1 and MCT4, along with their chaperone CD147 [10], emerge as key proteins in the metabolic reprogramming of cancer cells, being pointed out as potential therapeutic targets for cancer therapy [8, 11, 12]. This evidence concerns the gene BSG and cancer.